🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
SAR439459 is a human anti-Transforming growth factor β (TGFβ) monoclonal an...
Status
Terminated
Location
UCLA Health_Site Number: 8400006
Start Date
2022-08-25
Trial ID
NCT05231668
This is a phase Ib trial with SAR439459, a TGF-beta inhibitor, in combinati...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2021-02-09
Trial ID
NCT04729725
Treatments Being Tested
The purpose of this umbrella study is to evaluate isatuximab when combined ...
Status
Recruiting
Location
Winship Cancer Institute of Emory University- Site Number : 8400010
Start Date
2021-01-25
Trial ID
NCT04643002
Primary Objectives: Dose escalation (Part 1) Part 1A (SAR439459 monothera...
Status
Completed
Location
The University of Kansas Clinical Research Center Site Number : 8400004
Start Date
2017-06-09
Trial ID
NCT03192345
Treatments Being Tested